The Risk of Falls Index for Patients With Neuromuscular Disorders
- Conditions
- Inclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular DystrophiesThe Morse Fall ScaleMyasthenia GravisThe Falls Efficacy Scale International
- Interventions
- Diagnostic Test: The risk of falls
- Registration Number
- NCT05890833
- Lead Sponsor
- LMU Klinikum
- Brief Summary
The combination of short quantitatively assessing muscular function and balance in combination with short clinical scores, can be a new valid approach to evaluate the patient risk of fall and help to create a quick checkup test to prescribe an appropriate assistive device.
The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with neuromuscular diseases (NMD) based on correlation between clinical assessments between two groups of NMD patients and scales used to assess risk of falling for patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Patients between 18- and 65-year-old
- Patients with adequate cognitive and communication function to fill out the scales assessing risk of falling
- The neuromuscular disease needs to be confirmed by genetic report and/or disease deepening neurophysiological examination.
- Patients which are not able to perform motoric functional assessments without assistive gait device.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Neuromuscular disorders The risk of falls -
- Primary Outcome Measures
Name Time Method FBIndex 2 years The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with NMDs based on correlation between clinical assessments: Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed, Timed Up and Go test, 10 Meter Walk Test and Six Minute Walk test, between two groups of NMD patients and scales: "The Falls Efficacy Scale International FES-I" and "The Morse Fall Scale" used to assess risk of falling for patients.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Marko Mijic
🇩🇪München, Bavaria, Germany